Yoshiyuki Shioyama

SAGA Heavy Ion Medical Accelerator in Tosu

Papers

Total Citations

H-Index

About

Yoshiyuki Shioyama is a pioneering urologic surgeon whose research focuses on the intersection of advanced radiotherapy and robotic surgery for prostate cancer. His most notable contribution lies in demonstrating the feasibility and safety of salvage robot-assisted radical prostatectomy (RARP) following carbon ion radiotherapy—a highly specialized treatment for localized recurrence. In his landmark 2024 study, Shioyama reported the surgical and oncological outcomes of this challenging procedure at Kyushu University Hospital, providing critical evidence that salvage RARP can be performed with acceptable morbidity after carbon ion therapy. This work addresses a significant gap in the management of radio-recurrent prostate cancer, offering a curative option for patients who have exhausted non-surgical treatments. With 3 citations to date, his research is gaining traction among specialists in urologic oncology and radiation therapy. Shioyama’s contributions are particularly impactful for clinicians navigating the complexities of multimodal prostate cancer care, and his findings have been presented at major international meetings. His dedication to refining salvage techniques underscores his commitment to improving outcomes for patients with recurrent disease.